{
  "id": "ckd_prediction_hiv_patients",
  "title": "CKD Prediction in HIV+ Patients",
  "description": "Determines likelihood of HIV patients developing CKD in the next 5 years, whether they take tenofovir or not",
  "category": "nephrology",
  "version": "2014",
  "parameters": [
    {
      "name": "age_category",
      "type": "string",
      "required": true,
      "description": "Patient age category",
      "options": ["19_to_39", "40_to_49", "50_to_59", "60_to_90"],
      "validation": {
        "enum": ["19_to_39", "40_to_49", "50_to_59", "60_to_90"]
      },
      "unit": "years"
    },
    {
      "name": "glucose_elevated",
      "type": "string",
      "required": true,
      "description": "Glucose > 140 mg/dL",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "mg/dL"
    },
    {
      "name": "systolic_bp_elevated",
      "type": "string",
      "required": true,
      "description": "Systolic blood pressure > 140 mmHg",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "mmHg"
    },
    {
      "name": "hypertension",
      "type": "string",
      "required": true,
      "description": "Diagnosis of hypertension",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": ""
    },
    {
      "name": "triglycerides_elevated",
      "type": "string",
      "required": true,
      "description": "Triglycerides > 200 mg/dL",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "mg/dL"
    },
    {
      "name": "proteinuria",
      "type": "string",
      "required": true,
      "description": "Presence of proteinuria",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": ""
    },
    {
      "name": "cd4_low",
      "type": "string",
      "required": true,
      "description": "CD4+ count < 200 cells/µL",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "cells/µL"
    },
    {
      "name": "tenofovir_use",
      "type": "string",
      "required": true,
      "description": "Current or planned tenofovir (TDF) use",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": ""
    }
  ],
  "result": {
    "name": "ckd_risk_percentage",
    "type": "float",
    "unit": "percent",
    "description": "5-year CKD development risk percentage"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 5,
        "stage": "Low Risk",
        "description": "Low risk for CKD development",
        "interpretation": "Consider tenofovir use with routine monitoring"
      },
      {
        "min": 5,
        "max": 15,
        "stage": "Moderate Risk",
        "description": "Moderate risk for CKD development",
        "interpretation": "Careful consideration of tenofovir risks and benefits"
      },
      {
        "min": 15,
        "max": 100,
        "stage": "High Risk",
        "description": "High risk for CKD development",
        "interpretation": "Strong consideration for alternative to tenofovir"
      }
    ]
  },
  "references": [
    "Scherzer R, Gandhi M, Estrella MM, Tien PC, Deeks SG, Grunfeld C, Peralta CA, Shlipak MG. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS. 2014;28(9):1289-95.",
    "Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D Study Group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809."
  ],
  "formula": "Sum of risk factor points: Age (0-6) + Glucose >140 (2) + SBP >140 (1) + Hypertension (2) + Triglycerides >200 (1) + Proteinuria (2) + CD4+ <200 (1). 5-year CKD risk based on total score and tenofovir use status.",
  "notes": [
    "Based on prospective cohort study of HIV-positive male veterans",
    "Helps guide clinical decision-making around tenofovir use",
    "Traditional kidney risk factors are dominant contributors",
    "CD4+ count included but HIV RNA viral load is not a component",
    "Number needed to harm (NNH) for tenofovir decreases with higher scores",
    "Should be used in conjunction with clinical judgment",
    "Regular monitoring of kidney function recommended regardless of risk score"
  ]
}